Funding for this research was provided by:
National Institute on Drug Abuse (R01 DA030778, K24 DA022122, R34 DA045592)
National Institute of Allergy and Infectious Diseases (P30 AI042853)
National Institute of Allergy and Infectious Diseases (K23 AI112477)
National Center for Advancing Translational Sciences (CTSA UL1-RR024982)
Article History
Received: 16 December 2019
Accepted: 18 June 2020
First Online: 27 June 2020
Ethics approval and consent to participate
: This study was approved by the Institutional Review Board at University of Texas Southwestern Medical Center. Additional approvals were also obtained from Parkland Health and Hospital Systems and the Dallas County Jail.
: N/A
: AN receives research funding from Gilead FOCUS program. No other authors had conflicts of interest.